2025 Outlook: Will pharma sector get a shot in its arm in 2025?
Predictions for 2025: Pharma and healthcare mutual funds have offered the highest average return of around 38.05% in 2024 (from January 1, 2024 to December 3, 2024), as per an…
Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024
India’s healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According…
Indian pharma industry’s big pivot: Report reveals sector transitioning from generics to innovation
The Indian pharmaceutical industry is witnessing a profound transformation, transitioning from a generics-oriented hub to an innovation-driven pharmaceutical economy, largely attributed to its prominent Contract Development and Manufacturing Organizations (CDMOs).…
Health Ministry sets deadline for pharma industry to implement revised Schedule M
To bring in better quality management that will help Indian pharmaceutical manufacturers grow their business nationally and internationally, the Health Ministry has given six months for small manufacturers and 12…
US pharma industry seeks R&D policy for India’s pharma sector
Ahead of the Union Budget 2023-24, the US pharma industry has said that India should come out with a research and development policy for its pharmaceutical sector. Union Finance Minister…
Govt launches three schemes for Pharma Industry
New Delhi: The government launched three schemes to strengthen Micro, Small, and Medium Enterprises (MSMEs) in the pharmaceutical sector. Speaking at the launch event here, Union minister Mansukh Mandaviya noted that the schemes envisage technology up-gradation, the…
Rise in prices of Raw Materials for Pharma industry
The hike in the prices of petroleum products has caused a steep rise in the prices of raw materials required for the pharma industry which faces acute shortage of active pharmaceutical ingredients (APIs)…
No plea from pharma industry to resolve issues with USFDA – Govt
New Delhi Domestic pharmaceutical industry has not approached the government for early intervention to resolve regulatory issues faced by them in the US, Parliament was informed today. There is no…